Our Website Uses Cookies
We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.
For more information, please contact us or consult our Privacy Notice.
Your binder contains too many pages, the maximum is 40.
We are unable to add this page to your binder, please try again later.
This page has been added to your binder.
Bobby Lutzker helps clients in the life sciences and technology industries structure, draft and negotiate license, collaboration, supply, distribution and other commercial agreements.
- Natrogen Therapeutics International in agreements granting Takeda Pharmaceutical Company Limited an exclusive license to develop Natrogen’s leading compound and an option to acquire Natrogen.
- Gilead Sciences, Inc. in certain matters relating to the commercialization of Atripla, a triple combination product for the treatment of HIV.
- Amyris, Inc., a renewable products company, in several collaboration and commercial transactions.
- University of California, Santa Cruz in the creation of a national bioinformatics database and network to provide secure storage, access and cataloging of cancer-related genome data by leading cancer research facilities.
Memberships and Affiliations
- Berkeley Public Schools Fund, Board Member
August 8, 2014
SAN FRANCISCO, August 8, 2014 — Northern California Super Lawyers named Tammy Albarrán one of Northern California’s “Top 50 Women” lawyers and Robert Haslam one of the region’s “Top 100” lawyers. The publication selected 33 Covington & Burling lawyers for its 2014 list of top legal talent. Super Lawyers selects no more than five percent of the total lawyers who ...
Covington Advises Natrogen on Agreements with Takeda
December 20, 2013
WASHINGTON, DC, December 20, 2013 — Covington & Burling advised Natrogen Therapeutics International in its agreement with Takeda Pharmaceuticals for the exclusive license for worldwide development of Natura-alpha, a synthetic small molecule oral compound that is believed to inhibit pro-inflammatory cytokine expression, as well as an option to acquire Natrogen. ...
May 2, 2012
SAN FRANCISCO, May 2, 2012 — Covington & Burling LLP advised the University of California, Santa Cruz on the creation of a national, federally-financed bioinformatics database. The database will serve as a secure repository for storing, cataloging, and accessing cancer genome sequences, alignments, and mutation information from leading cancer-related projects ...
Covington Advises Microsoft in Standards-Essential Wireless Patents Portfolio Transaction with MOSAID and Nokia
September 2, 2011
SAN FRANCISCO, September 2, 2011 — Covington & Burling LLP represented Microsoft Corp. in a patent monetization transaction involving the acquisition by MOSAID Technologies Incorporated of Core Wireless Licensing S.a.r.l., a Luxembourg company that holds a portfolio of 400 patent families, consisting of approximately 2,000 wireless patents and patent ...
Covington Advises Microsoft in $8.5 Billion Skype Deal
May 10, 2011
WASHINGTON, SAN FRANCISCO, BRUSSELS, AND LONDON, May 10, 2011 —Covington & Burling LLP is advising Microsoft Corp. in its acquisition of Skype Global S.à.r.l., the leading Internet communications company, for $8.5 billion in cash. Microsoft’s purchase of Skype from the investor group led by Silver Lake is expected to increase the accessibility of real-time ...
July 15, 2010
WASHINGTON, DC, July 15, 2010 — Covington & Burling LLP is pleased to announce the signing of a Purchase Agreement for the sale of the Golden State Warriors, the NBA franchise based in Oakland, California, to an investor group led by Kleiner Perkins Caufield & Byers Managing Partner Joe Lacob and Mandalay Entertainment Group Chairman Peter Guber. The sale price ...
Covington Advises Prosper Marketplace on Series D Round
April 19, 2010
SAN FRANCISCO, April 19, 2010 — Prosper.com, the world’s largest peer-to-peer lending marketplace with nearly one million members and more than 32,000 funded loans totaling over $194 million, announced that it has raised $14.7 million in a Series D round from new investors TomorrowVentures, LLC and CompuCredit Holdings Corporation, and all of Prosper’s existing ...
December 17, 2009
NEW YORK, December 17, 2009 — Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat, have announced a definitive merger agreement whereby Ethicon ...
November 16, 2009
SAN FRANCISCO, CA, November 16, 2009 — Fate Therapeutics, Inc. announced today that it has completed a $30 million series B financing led by OVP Venture Partners. Covington & Burling LLP advised OVP on the transaction. Also participating in the financing were ARCH Venture Partners, Polaris Venture Partners and Venrock, which collectively led the company’s series ...
- Northern California Super Lawyers, Business/Corporate "Rising Star" (2013-2018)